ZOMETA® Safety & Tolerability: Acute Phase Reactions
Home


About ZOMETA

ZOMETA Patient Case Studies

Zometa Dosing & Administration

ZOMETA Safety & Tolerability
Acute Phase Reactions
Renal Safety
Dental Health

ZOMETA Clinical News

ZOMETA For Your Patients

Professional Resource Center

ZOMETA Around the World
Videos
View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

 
European Summary of Product Characteristics
For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics
 
ZOMETA Safety & Tolerability: Acute Phase Reactions


acute phase reactions managing reactions references

Acute phase reactions are mild and transient

  • Intravenous bisphosphonates have been associated with a flu-like reaction, such as fever or bone pain1
  • These reactions are typically self-limited and resolve within 1 to 2 days of administration2
  • For most patients, reactions lessen with subsequent infusions2